-
-
Cisplatin has long been considered the standard first-line chemotherapy of choice for cervical cancer patients demonstrating disease recurrence.
-
Cases of laparoscopic appendectomies at Walter Reed Army Medical Center were retrospectively reviewed. Emergency cases and ruptured appendixes were excluded.
-
What to do with the Cox-2s; Can Mucomyst Prevent CIN?; Benzodiazepines and Medicare Coverage; FDA Actions
-
-
-
The next patient in your exam room is in her mid-20s. While she is in generally good health, you note she weighs in at 210 pounds. What contraceptive methods do you offer her?
-
Investigators now are looking at a transcervical sterilization option that, if proven safe and effective, will give women another alternative for permanent contraception.
-
The 15-year-old young woman in your exam room tells you that she has crampy pelvic pain that begins shortly before or at the onset of her menstrual period that lasts one to three days. She says she usually misses a day of school each month due to the pain. What is your next move?
-
The push is on to develop an effective male contraceptive, with almost $8 million from the National Institutes of Health (NIH) going to researchers at the University of Kansas in Lawrence and the University of Kansas Medical Center in Kansas City toward identifying potential chemical compounds for such use.
